|
BALTIMORE, MD—November 12, 2013—The College of Physicians and Surgeons of Columbia University and Med-IQ, an award-winning, ACCME-accredited provider of continuing medical education (CME), are sponsoring a new CME initiative, now available for clinicians in the federal healthcare system. This free publication is designed to help clinicians better identify and overcome barriers related to the management of schizophrenia and understand the appropriate use of long-acting injectable (LAI) antipsychotics in clinical practice.
"Despite their benefits, LAI medications are often under-used when treating schizophrenia," said William A. Mencia, MD, CCMEP, Vice President of Education & Medical Affairs at Med-IQ. "This initiative helps highlight the potential for antipsychotic therapy to improve long-term outcomes, particularly related to the prevention of relapses, in the context of appropriate patient selection."
Participants will discuss the frequency and consequences of treatment nonadherence in patients with schizophrenia in the VA health system. They will also identify barriers to the use of LAIs within the federal healthcare system and develop strategies for overcoming them.
FACULTY
 |
|
Robert W. Buchanan, MD
Professor of Psychiatry
Interim Director, Maryland Psychiatric
Research Center
Baltimore, MD
|
| |
|
|
 |
|
Mark Olfson, MD, MPH
Professor of Clinical Psychology
Columbia University Medical Center
New York, NY
|
The publication was originally offered as a supplement to the monthly publication, U.S. Medicine: The Voice of Federal Medicine, and is currently available online at www.Med-IQ.com/a718.
The College of Physicians and Surgeons of Columbia University is accredited by the Accreditation Council for Continuing Medical Education (ACCME) to provide continuing medical education for physicians.
The College of Physicians and Surgeons designates this enduring material for 0.75 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
This activity is supported by an educational grant from Janssen Pharmaceuticals, Inc., administered by Janssen Scientific Affairs, LLC.
|
|
About Med-IQ
Med-IQ, America's most respected provider of continuing medical education (CME), inspires healthcare professionals through award-winning activities that deliver sophisticated outcomes-based educational designs with measurable results in professional competence and performance. Med-IQ is accredited by the Accreditation Council for Continuing Medical Education (ACCME), the California Board of Registered Nursing (CBRN), and the Accreditation Council for Pharmacy Education (ACPE) as a provider of continuing medical education to physicians, nurses, and pharmacists, respectively.
Med-IQ, a leader in the development of performance improvement (PI) and quality improvement (QI) CME initiatives, has been recognized by the Alliance for Continuing Education in the Health Professions for our excellence in CE research (William Campbell Felch Award 2013, 2011), educational collaborations (2013), outstanding CME outcomes assessment (2012), and exceptional leadership (Leadership Award 2013, President’s Award 2012). To learn more about Med-IQ, visit www.Med-IQ.com, like us on Facebook, follow us on Twitter, and connect with us on LinkedIn.
For more information, contact:
|
